iTeos Therapeutics, Inc. (ITOS) Financials

ITOS Assets vs Liabilities

DateAssetsLiabilities
March 31, 2025 658.9 million 95.4 million
Dec. 31, 2024 687.0 million 96.7 million
Sept. 30, 2024 723.1 million 91.4 million
June 30, 2024 751.8 million 88.0 million

ITOS Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2025 -33.9 million 6.6 million
Dec. 31, 2024 5.3 million 7.1 million
Sept. 30, 2024 -37.4 million 7.5 million
June 30, 2024 -34.4 million 8.1 million

ITOS Net Income

No data available :(

ITOS Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2025 520.4 million - 5.1 million
Dec. 31, 2024 494.6 million 3.8 million 5.1 million
Sept. 30, 2024 488.7 million 4.2 million 5.5 million
June 30, 2024 571.3 million 4.2 million 5.5 million

ITOS Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2025 43.2 million
Dec. 31, 2024 40.5 million
Sept. 30, 2024 43.1 million
June 30, 2024 39.7 million

ITOS Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2025 101000 29.0 million 11.0 million -
Dec. 31, 2024 152000 37.5 million 11.8 million -
Sept. 30, 2024 94000 36.7 million 12.1 million -
June 30, 2024 442000 36.4 million 12.5 million -

ITOS Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2025 - -
Dec. 31, 2024 - -
Sept. 30, 2024 - -
June 30, 2024 35.0 million 309000

ITOS Revenue by Segment

Graph available only for paid members. Upgrade to see it.

ITOS

Price: $10.15

52 week price:
4.80
17.63

Earnings Per Share: -4.73 USD

P/E Ratio: -2.15

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 231111

Market Capitalization: 448.7 million

Links: